The efficacy and cardiac toxicity of different‐dose pegylated liposomal doxorubicin in elderly patients with diffuse large B lymphoma

OBJECTIVES: In order to explore the impact of pegylated liposomal doxorubicin (PLD) dose intensity on survival outcomes of newly diagnosed elderly patients with diffuse large B‐cell lymphoma (DLBCL), we performed a retrospective study to compare the efficacy and adverse effects of RCEOP (70 mg/m(2))...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Chen, Rongrong, Zhou, De, Sun, Jianai, Wang, Lulu, Zhu, Lixia, Shen, Huafei, Xie, Wanzhuo, Ye, Xiujin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972167/
https://www.ncbi.nlm.nih.gov/pubmed/36200320
http://dx.doi.org/10.1002/cam4.5280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972167/
https://www.ncbi.nlm.nih.gov/pubmed/36200320
http://dx.doi.org/10.1002/cam4.5280

Ejemplares similares